IgD multiple myeloma a descriptive report of 17 cases: Survival and response to therapy

Journal of Experimental and Clinical Cancer Research

Volumn 31, Issue 1, 2012, Pages

  Pisani, Francesco ^a   Petrucci, Maria Teresa ^b   Giannarelli, Diana ^a   Bongarzoni, Velia ^c   Montanaro, Marco ^d   De Stefano, Valerio ^e   La Verde, Giacinto ^f   Gentilini, Fabiana ^b   Levi, Anna ^b   Za, Tommaso ^e   Moscetti, Alessandro ^f   Annino, Luciana ^c   Petti, Maria Concetta ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c SAN GIOVANNI ADDOLORATA HOSPITAL   (Italy)

^d BELCOLLE HOSPITAL   (Italy)

^e CATHOLIC UNIVERSITY   (Italy)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; CALCIUM; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IMMUNOGLOBULIN D; IMMUNOGLOBULIN LAMBDA CHAIN; MELPHALAN; THALIDOMIDE; VINCRISTINE; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE LESION; CALCIUM BLOOD LEVEL; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; DRUG DOSE REGIMEN; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DYSFUNCTION; MALE; MEDICAL RECORD REVIEW; MULTIPLE MYELOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; TREATMENT RESPONSE; AUTOTRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MIDDLE AGED; MORTALITY; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOGLOBULIN D; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 84857546966     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-31-17     Document Type: Article

References (19)

1. Nonsecretory myeloma, immunoglobulin D myeloma, and plasma cell leukemia. Bladé J, Kyle RA, ematol Oncol Clin North Am 1999 13 1259 1272 10.1016/S0889-8588(05)70125-8 (Pubitemid 30017399)
2. IgD multiple myeloma. Review of 133 cases. Jancelewicz Z, Takatsuki K, Sugai S, Pruzanski W, Arch Intern Med 1975 135 87 93 10.1001/archinte.1975. 00330010089012 1111472
3. Prognostic factors in IgD myeloma: study of 21 cases. Fibbe WE, Jansen J, Scand J Haematol 1984 33 471 475 6515330 (Pubitemid 15180567)
4. Immunoglobulin D multiple myeloma presenting features response to therapy, and survival in a series of 53 cases. Bladé J, Lust JA, Kyle RA, J Clin Oncol 1994 12 2398 2404 7964956 (Pubitemid 24346713)
5. IgD myeloma: clinical, biological and laboratory features. Sinclair D, Clin Lab 2002 48 617 622 12465746 (Pubitemid 35415025)
6. A new risk grouping for IgD myeloma based on analysis of 165 Japanese patients. Shimamoto Y, Anamy Y, Yamaguchi M, Eur J Haematol 1991 47 262 267 1954984
7. Long-term complete remission in IgD-myeloma. Bemelmans RH, van Toorn DW, van Leeuwen L, Schaar CG, Eur J Haematol 2006 76 339 341 10.1111/j.1600-0609. 2005.00600.x 16519706 (Pubitemid 43362943)
8. IgD monoclonal gammopathy with long-term follow-up. Bladé J, Kyle RA, Br J Haematol 1994 88 395 396 10.1111/j.1365-2141.1994.tb05037.x 7803288 (Pubitemid 24318192)
9. IgD multiple myeloma: a cure at 21 years. Kyle RA, Am J Hematol 1988 29 41 43 10.1002/ajh.2830290110 3177368
10. Long-term survival in a case of high-risk type IgD myeloma: a possibility of effectiveness of interferon-alpha and erythropoietin. Hiyoshi M, Hashimoto S, Ota T, Nakao T, Takubo T, Tagawa S, Tatsumi N, Haematologia (Budapest) 1997 28 177 180 (Pubitemid 27339751)
11. IgD multiple myeloma- a clinical profile and outcome with chemotherapy and autologous stem cell transplantation. Wechalekar A, Amato D, Chen C, Keith SA, Reece D, Ann Hematol 2005 84 115 117 10.1007/s00277-004-0944-x 15503021 (Pubitemid 40089768)
12. The outcome of IgD myeloma after autologous hematopoietic stem cell transplantation is similar to other Ig subtypes. Sharma M, Qureshi SR, Champlin RE, Popat U, Giralt S, Qazilbash MH, Am J Hematol 2010 85 502 504 10.1002/ajh.21740 20575022
13. High-dose chemotherapy followed by autologous stem cell transplantation changes prognosis of IgD multiple myeloma. Maisnar V, Hájek R, udla V, Gregora E, Büchler T, Tich M, Kotouek P, Bláha V, Mal J, Bone Marrow transplantation 2008 41 51 54 10.1038/sj.bmt.1705881 17934529
14. Outcome of patients with IgD and IgM multiple myeloma undergoing autologous hematopoietic stem cell transplantation: a retrospective CIBMTR study. Reece DE, Vesole DH, Shrestha S, Zhang MJ, Pérez WS, Dispensieri A, Milone GA, Abidi M, Atkins H, Bashey A, Bredenson CN, Boza WB, Freytes CO, Gale RP, Gajewski JL, Gibson J, Hale GA, Kumar S, Kyle RA, Lazarus HM, Mccarthy PL, Pavlovsky S, Roy V, Weisdorf DJ, Wiernik PH, Hart PN, Clin Lymphoma myeloma Leuk 2010 10 458 463 10.3816/CLML.2010.n.078 21156462
15. Efficacy and outcome of autologous transplantation in rare myelomas. Morris C, Drake M, Apperly MJ, Iacobelli S, van Biezen A, Bjorkstrand B, Goldschmidt H, Harousseau JL, Morgan G, de Witte T, Niederwieser D, Gahrton G, Haematologica 2010 95 2126 2133 10.3324/haematol.2010.022848 20971818
16. International uniform response criteria for multiple myeloma. Durie BG, Harousseau JL, Miguel JS, Bladé J, Barlogie B, Anderson K, Gertz M, Dimopoulos M, Westin J, Sonneveld P, Ludwing H, Gahrton G, Beksac M, Crowley J, Belch A, Boccadoro M, Cavo M, Turesson I, Joshua D, Vesole D, Kyle R, Alexanian R, Tricot G, Attal M, Merlini G, Powles R, Richardson P, Shimizu K, Tosi P, Morgan G, Rajkumar SV, on behalf of the International Myeloma Working Group, Leukemia 2006 20 1467 1473 10.1038/sj.leu.2404284 16855634 (Pubitemid 44264086)
17. Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma. Kyle RA, Rajkumar SV, Leukemia 2009 23 3 9 10.1038/leu.2008.291 18971951
18. Immunoglobulin D multiple myeloma response to therapy, survival and prognostic factors in 75 patients. Kim MK, Suh C, Lee DH, Min CK, Kim SJ, Kim K, Moon JH, Yoon SS, Lee G-W, Hang HJ, Kim S-H, Choi CW, Eom HS, Kwak J-Y, Kim HJ, Mun Y-C, Bang S-M, Lee K, Shin HJ, Lee JH, Ann Oncol 2011 22 411 416 10.1093/annonc/mdq393 20682550
19. Immunoglobulin D myeloma-problems with diagnosis and staging (own experience and literature review). Kuliszkiewicz-Janus M, Zimny A, Sokolska V, Saiadek M, Kuliczkowski K, Leuk Lymphoma 2005 46 1029 1037 10.1080/ 00268970500096442 16019554 (Pubitemid 40975023)